Osteoporosis, RA & Gout Flashcards

1
Q

Uricemia due to excess synthesis, diet intake, or excess cell turnover

A

overproducer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What activates NFkB?

A

RANKL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What governs the formation & activation of osteoclasts?

A

RANKL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Indication for DULOXETINE

A

SNRI used to tx OA

increased risk for constipation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are tophi?

A

large aggregations of monosodium urate crystals surrounded by intense inflammatory reaction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is a pathognomonic hallmark of gout?

A

tophi

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is an absolute CI for tx of RA w/ MTX?

A

PREGNANCY

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

MOA of uricosuric drugs

A

lower serum urate levels by increasing urate fractional excretion by kidneys

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

MOA & use of prednisone

A

glucocorticoid

short term use in tx for RA until DMARD effects are seen

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Sxs of OA

A

localized pain, stiffness, tenderness, crepitus, bone spurs (joint mice)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

MOA & use of ANAKINRA

A

late choice biologic DMARD (limited efficacy)

recombo version of endogenous human IL-1 receptor antagonist

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

AEs of SERMs (raloxifene)

A

DVT
PE
Stroke

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

MOA & use of infliximab

A

biologic DMARD, monoclonal AB v TNFa

IV every 6 weeks

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

MOA & use of tofacitinib

A

biologic DMARD, JAK3 antagonist

orally active

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

MOA & use of tocilizumab

A

biologic DMARD, humanized anti IL-6 receptor AB

decrease acute phase response of liver in RA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

MOA of febuxostat

A

non purine, non competitive xanthine oxidase inhibitor

reduce urate levels in pts w/ allopurinol intolerance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

MOA & use of pegloticase

A

PEGylated version of recombo mammal uricase

tx chronic gout in those refractory to conventional tx

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What is NOT altered by use of NSAIDs or glucocorticoids in RA?

A

disease progression

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What should pts take if on MTX or sulfasalazine in tx of RA?

A

B9 (folate) supplement

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

What hormone acts to increase free Ca2+ levels in plasma?

A

PTH

increases bone breakdown, promotes reabsorption of Ca2+ in kidney & promotes generation of calcitriol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Indication & AEs of Ca2+ salts

A

diet supplement in teen & post meno Fs to facilitate bone growth or limit bone loss

AEs w/ constipation, lethargy, polyuria, kidney stones

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

MOA & use of colchicine

A

blocks tubulin polymerization (& MT formation) in leukocytes which needed for migration & phagocytosis

tx acute gout in pts who cannot take NSAIDs & relieves inflammation w/ in 12-24hrs of sxs

23
Q

MOA & use of rasburicase

A

non peg recombo uricase

prevention of acute uric acid nephropathy due to tumor lysis syndrome

24
Q

MOA & use sulfinpyrazone

A

uricosuric agent

requires GFR>60, only works for under excreters of uric acid

25
MOA & use of hydroxychloroquine
traditional DMARD that alters antigen presentation by disrupting lysosomal pH tx of RA
26
Indication for cinacalcet
secondary hyperPTH caused by CKD
27
MOA & use of denosumab
monoclonal AB v RANKL to lower its bone microenviro levels relative to OPG (decreases formation & function of osteoclasts) tx of osteoporosis
28
MOA & use of allopurinol
competitive xanthine oxidase inhibitor that lowers serum urate levels standard tx of recurrent gout if low GFR or past urate stone or urate overproduction
29
MOA & use of leflunomide
disrupts pyrimidine synthesis 2nd choice traditional DMARD for RA
30
MOA & use of raloxifene
SERM w/ agonist effects on bone tx of osteoporosis
31
What type of tx for prostate cancer increases pt risk for developing osteoporosis?
androgen deprivation
32
What type of bone is broken in atypical femoral fractures due to bisphosphonate tx?
cortical bone
33
What autoABs in RA pts that target protein arginine residues?
cirtulline (anti CCP)
34
MOA & use of indomethacin
NSAID w/ COX1 selectivity tx acute gouty arthritis
35
MOA & use of abatacept
biologic DMARD that blocks T cell CD80/86 co stimulatory signal needed for activation tx of RA
36
What is uric acid?
poorly soluble end product of purine metabolism cuase of kidney stones
37
MOA & use of teriparatide
1-34 PTH only agent that FORMS bone via PULSED daily therapy tx of osteoporosis
38
Major AE of hydroxychloroquine
retinal damage
39
MOA & use methotrexate
traditional DMARD must monitor for myelosuppression, tx of RA
40
AE of colchicine
GI distress
41
How to tx hyperCa2+ of malignancy?
w/ bisphosphonates or furosemide
42
MOA of cinacalcet
Ca2+ receptor sensitizer acts to lower PTH secretion
43
What is triple tx for RA?
MTX Hydroxychloroquine Sulfasalazine
44
MOA & use of alendronate
bisphosphonate, incorporates into bone to inhibit # & activity of osteoclasts 1st choice to tx osteoporosis in M & F
45
MOA & use of sulfasalazine
traditional DMARD used for RA AEs of GI side effects
46
MOA & use of adalimumab
antiTNF biologic DMARD tx psoriatic arthritis, ankylosing spondylitis
47
MOA, use & major AE of zoledronic acid
bisphosphonate, IV injection 1x/year for tx of osteoporosis highest risk of ONJ
48
MOA & use rituximab
targets CD20 on B cells tx RA
49
MOA & use of probenecid
blocks urate reabsorption @ URAT1 transporter in kidney prox tubule increase excretion of urate in urine to tx gout
50
Major AE of allopurinol
Stevens Johnson syndrome (fatal epidermal necrolysis) mc HLAB5801
51
Major AE of oral bisphosphonates
esophagitis
52
MOA of etanercept
biologic DMARD, sc injection 1-2x/week tx for psoriasis
53
What is a common target to tx RA & other autoimmune dzs?
TNFa block